Liebert/Sage Young Investigator Award Applications Now Being Accepted
Clinical Report: Applications Open for the Liebert/Sage Young Investigator Award
Overview
The Liebert/Sage Young Investigator Award offers $1,500 to two early-career researchers in respiratory therapy.
Background
The Young Investigator Award, established in 2025, recognizes early-career researchers in respiratory therapy.
Data Highlights
No numerical or trial data available.
Key Findings
- The award recognizes two early-career investigators annually.
- Applicants must be current AARC members and RRTs with a minimum baccalaureate degree.
- Nominees should have at least 5 peer-reviewed publications or abstracts.
- The nomination package must include a nomination letter, CV, and published work.
- The nomination period closes on August 15, 2026.
Clinical Implications
The Young Investigator Award provides recognition for emerging researchers in respiratory therapy.
Conclusion
The Young Investigator Award promotes research in respiratory therapy.
Related Resources & Content
- The ASCO Post, 2017 -- NCCN Foundation Announces Fifth 2017 Young Investigator Award
- The ASCO Post, 2020 -- The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early-Career Researchers
- The ASCO Post, 2014 -- Paying It Forward: Breakthrough Prize Winners and Institutions Commit $3 Million in Support of Next Generation of Scientists
- The ASCO Post, 2017 -- ANCO Supports Young Investigator Award for a Northern California Researcher
- American Journal of Respiratory and Critical Care Medicine, 2026 -- Noninvasive Respiratory Support for Adult Patients with Acute Respiratory Failure
- Global Initiative for Chronic Obstructive Lung Disease, 2026 -- Global Initiative for Chronic Obstructive Lung Disease 2026 Report
- Noninvasive Respiratory Support for Adult Patients with Acute Respiratory Failure. An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine | Oxford Academic
- Global Initiative for Chronic Obstructive Lung Disease 2026 Report
- High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure | New England Journal of Medicine